Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 24, 2016	Dec. 26, 2015
Cash flows from operating activities:
Net income	$ 226,151	$ 109,618
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	47,989	43,254
Stock compensation expense	28,708	24,717
Deferred income taxes	5,285	8,021
Loss on retirement or write-off of long-lived assets	424	1,405
Actuarial (gain) loss amortization on defined benefit pension plan	64
Excess tax benefit from employee stock awards		(9,350)
Other non-cash charges	(2,547)	14,381
Net change in operating assets and liabilities:
Accounts receivable, net	(158,098)	(15,066)
Inventories	(12,113)	(53,527)
Other current assets	(1,279)	(4,645)
Accounts payable and other accrued liabilities	96,673	861
Deferred income		(1,943)
Income taxes payable	13,636	(1,428)
Net cash provided by operating activities	244,893	116,298
Cash flows from investing activities:
Maturities and sales of available-for-sale marketable securities	157,234	117,397
Purchases of available-for-sale marketable securities	(148,342)	(22,672)
Purchases of property, equipment and software	(26,380)	(33,720)
Investments in technology	(8,920)	(3,981)
Acquisition of businesses, net of cash obtained		(36,788)
Increase in deposits and other assets		(2,012)
Net cash (used in) provided by investing activities	(26,408)	18,224
Cash flows from financing activities:
Principal payments on long-term revolver	(60,439)	(20,000)
Debt issuance costs	(2,152)
Payments on capital lease agreements	(699)
Issuance of common stock, net of shares withheld for taxes	14,869	4,958
Repurchase of stock to satisfy employee tax withholding obligations	(13,043)	(6,459)
Repurchase and retirement of common stock	(15,439)	(39,200)
Excess tax benefit from employee stock awards		9,350
Net cash used in financing activities	(76,903)	(51,351)
Net decrease in cash and cash equivalents	141,582	83,171
Cash and cash equivalents at beginning of period	168,793	168,793
Cash and cash equivalents at end of period	$ 310,375	$ 159,572